For the treatment of patients with mild to moderate infections caused by susceptible strains of the designated
micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis and community acquired pneumonia in patients suitable for outpatient oral treatment and in patients who require initial intravenous therapy).
• Upper respiratory tract infections (acute sinusitis, acute streptococcal
  pharyngitis/tonsillitis and acute otitis media in children).
• Uncomplicated skin and skin structure infections.
• Sexually transmitted diseases (uncomplicated urethritis and cervicitis).
  Antimicrobial agents used in high doses for short periods of times to treat non-gonococcal urethritis may mask or delay the symptoms of incubating gonorrhea or syphilis. All patients with sexually-transmitted urethritis or cervictitis should have a serologic test for syphilis and appropriate cultures for gonorrhea performed at the time of diagnosis.
  Appropriate antimicrobial therapy and follow-up tests for these diseases should be initiated if infection is confirmed.
• Pelvic inflammatory disease in patients who require initial intravenous therapy.
• Chlamydia trachomatis conjunctivitis and trachoma in adults and in children 12 months or older.
• Prophylaxis and treatment of disseminated mycobacterium avium complex (MAC) disease in adults and children aged more than 12 years.